Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

OBJECTIVE: Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ), and the risk appears to be increased in patients treated with tofacitinib. The aim of this study was to evaluate whether concomitant treatment with conventional synthetic disease‐modifying antirheumatic d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Rheumatol
Autors principals: Winthrop, Kevin L., Curtis, Jeffrey R., Lindsey, Stephen, Tanaka, Yoshiya, Yamaoka, Kunihiro, Valdez, Hernan, Hirose, Tomohiro, Nduaka, Chudy I., Wang, Lisy, Mendelsohn, Alan M., Fan, Haiyun, Chen, Connie, Bananis, Eustratios
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Rheumatoid Arthritis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656820/
https://ncbi.nlm.nih.gov/pubmed/28845604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars